José Alberto Orfao de Matos Correia e Vale-rekin lankidetzan egindako argitalpenak (10)
2023
-
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice
Nature Communications, Vol. 14, Núm. 1
2022
-
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
Cancer research, Vol. 82, Núm. 6, pp. 1098-1109
2021
-
The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia
Frontiers in Cell and Developmental Biology, Vol. 9
2020
-
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis
Scientific Reports, Vol. 10, Núm. 1
2019
-
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID
Nature Communications, Vol. 10, Núm. 1
2018
-
Lmo2 expression defines tumor cell identity during T-cell leukemogenesis
EMBO Journal, Vol. 37, Núm. 14
-
Loss of Pax5 exploits sca1-BCR-ABLp190 susceptibility to confer the metabolic shift essential for pB-ALL
Cancer Research, Vol. 78, Núm. 10, pp. 2669-2679
2015
-
Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility
Cancer Discovery, Vol. 5, Núm. 12, pp. 1328-1343
2014
-
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma
Nature Communications, Vol. 5
2012
-
A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors
EMBO Journal, Vol. 31, Núm. 18, pp. 3704-3717